540496-34-2

Basic information

• Product Name: 4-Oxazolidineacetic acid, 2-oxo-, phenylmethyl ester, (4S)-
• CAS NO: 540496-34-2
• Molecular Formula: C12H13NO4
• Molecular Weight: 235.24
• Mol File: 540496-34-2.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 4-Oxazolidineacetic acid, 2-oxo-, phenylmethyl ester, (4S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Oxazolidineacetic acid, 2-oxo-, phenylmethyl ester, (4S)-(540496-34-2)
• EPA Substance Registry System: 4-Oxazolidineacetic acid, 2-oxo-, phenylmethyl ester, (4S)-(540496-34-2)

Safety Data

• Hazardous Substances Data: 540496-34-2(Hazardous Substances Data)

Upstream product

• 4515-23-5 N-benzyloxycarbonyl-L-aspartic acid anhydride 
• 2177-63-1 (S)-2-amino-4-(benzyloxy)-4-oxobutanoic acid 
• 79069-52-6 N-Boc-L-aspartic aldehyde β-benzyl ester 
• 161745-47-7 benzyl 3(S)-<(tert-butoxycarbonylamino)>-4-p-toluenesulfonyl-1-butyrate 
• 1152-61-0 N-Cbz-L-Asp 
• 84890-97-1 (S)-3-tert-Butoxycarbonylamino-4-isobutoxycarbonyloxy-4-oxo-butyric acid benzyl ester 
• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 79069-16-2 benzyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-hydroxybutanoate 
• 87219-29-2 benzyl (3S)-5-oxotetrahydro-3-furanylcarbamate 
• 100-39-0 benzyl bromide 

Downstream Products

• 760979-68-8 {(S)-3-[2-((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetyl]-2-oxo-oxazolidin-4-yl}-acetic acid benzyl ester 
• 760979-71-3 [(S)-3-(2-{(S)-3-[2-((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetyl]-2-oxo-oxazolidin-4-yl}-acetyl)-2-oxo-oxazolidin-4-yl]-acetic acid benzyl ester 
• 760979-74-6 ((S)-3-{2-[(S)-3-(2-{(S)-3-[2-((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetyl]-2-oxo-oxazolidin-4-yl}-acetyl)-2-oxo-oxazolidin-4-yl]-acetyl}-2-oxo-oxazolidin-4-yl)-acetic acid benzyl ester 
• 603142-91-2 (4S)-4-(2-fluoro-2-methylpropyl)-1,3-oxazolidin-2-one 
• 760979-67-7 ((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetic acid pentafluorophenyl ester 
• 760979-70-2 {(S)-3-[2-((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetyl]-2-oxo-oxazolidin-4-yl}-acetic acid pentafluorophenyl ester 
• 760979-73-5 [(S)-3-(2-{(S)-3-[2-((S)-3-Acetyl-2-oxo-oxazolidin-4-yl)-acetyl]-2-oxo-oxazolidin-4-yl}-acetyl)-2-oxo-oxazolidin-4-yl]-acetic acid pentafluorophenyl ester 
• 540496-36-4 [(S)-3-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyryl)-2-oxo-oxazolidin-4-yl]-acetic acid benzyl ester 

Relevant articles and documents

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

This invention relates to deuterated compounds which are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

The invention is directed to a formula (I), or a pharmamceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Cathepsin cysteine protease inhibitors

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is i